Prevalence significantly lower among Hispanic and Asian individuals; in young adults, prevalence highest in Blacks
THURSDAY, April 28, 2022 (HealthDay News) — The prevalence of multiple sclerosis (MS) is similarly high in Black and White individuals and is lower in Hispanics and Asians, according to a study published online April 27 in Neurology.
Annette M. Langer-Gould, M.D., Ph.D., from the Los Angeles Medical Center, and colleagues conducted a retrospective cohort study involving more than 2.6 million adults from Kaiser Permanente Southern California to examine whether the prevalence of MS varies by race and ethnicity.
A total of 3,863 patients with MS were identified. The researchers found that the average age of prevalent MS patients was 51.7 years; 76.8 percent were women. The female preponderance was more pronounced among Black and Asian versus White or Hispanic individuals with MS (81.2 and 83.6 versus 76.3 and 74.5 percent, respectively). Blacks and Whites had similarly high age- and sex-standardized MS prevalence (225.8 and 237.7 per 100,000, respectively), while prevalence was significantly lower among Hispanic and Asian persons (69.9 and 22.6, respectively). Across all racial and ethnic groups, MS prevalence was highest between ages 35 and 64 years and decreased after age 65 years. The crude MS prevalence was low among adults aged 18 to 24 years but was highest in Blacks and Hispanics, lower in Whites, and lowest in Asian/Pacific Islander individuals (48.5, 25.0, 18.0, and 7.1 per 100,000, respectively).
“Understanding MS prevalence in all people has important implications when it comes to making sure people are properly screened and treated for this disease,” Langer-Gould said in a statement.
One author disclosed financial ties to Acumen Inc.
Abstract/Full Text (subscription or payment may be required)
Pulse Oximetry-Based Scoring May Miss Sleep Apnea Events in Black Patients
Few Meet Major Clinical Response Criteria After Treatment Escalation for Lupus
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026
MHT Initiation May Reduce Cardiovascular Risk in Women With Vasomotor Symptoms
Women With Autism May Experience More Severe Menopause
Oral Menopausal Hormone Therapy Linked to Venous Thromboembolic Risk
Longer Reproductive Lifespan Tied to Lower Bronchiectasis Risk in Postmenopausal Women
Midlife Onset of Increasing Pulse Pressure Not Linked to Menopause